Childhood Virus Linked to Bladder Cancer: Immune Response might potentially be Key
Table of Contents
A common childhood infection, the BK virus (BKV), may be unexpectedly linked to the development of bladder cancer, according to new research published December 3 in the journal Science Advances. Scientists are now investigating how the body’s own immune response to the virus could trigger DNA damage that ultimately leads to cancer, especially in individuals with compromised immune systems.
People undergoing kidney transplants face a three-fold increased risk of developing bladder cancer,and BKV is known to remain dormant in the kidneys after childhood infection. This raises a critical question: can this seemingly harmless virus contribute to cancer development years, even decades, after the initial infection?
The recent study reveals a surprising mechanism. Researchers discovered that BKV doesn’t directly cause cancer-inducing mutations. Instead, the virus triggers an overreaction from the body’s immune system, specifically a family of enzymes called APOBEC.
“This is a nicely-done laboratory study to show a possible way that BKV could have a larger role in bladder cancer than previously thought,” noted a tumor virology researcher at the University of Pittsburgh who was not involved in the study.
For decades, bladder cancer has primarily been attributed to environmental factors like smoking and industrial chemical exposure. Though, the patterns of DNA mutations observed in bladder cancers don’t always align with those caused by these known carcinogens. Rather, these cancers exhibit a distinct “mutational signature” linked to APOBEC enzymes.
Normally, APOBEC enzymes are crucial components of the body’s antiviral defense system. They work by attacking the genomes of viruses, preventing them from replicating. However, the new research suggests that in response to BKV infection, these enzymes can become overactive and begin damaging the DNA of healthy cells.
Researchers at the University of York in the U.K. infected healthy human bladder cells with BKV in a laboratory setting.They observed that the cells developed mutations similar to those found in bladder cancer, alongside a notable increase in APOBEC3 activity. Crucially, when APOBEC3 was deactivated, the DNA damage did not occur, indicating the enzyme – not the virus itself – was the primary culprit.
“bystander” Cells and the Spread of Mutation
The study revealed another unexpected finding: DNA damage and increased APOBEC3 expression were also observed in “bystander” cells – cells that hadn’t been directly infected with BKV. This suggests that the immune response triggered by the virus can have a ripple effect, causing genetic mutations in surrounding tissues.
“That was a surprise,” explained senior study author Simon Baker, a cancer researcher at the University of York. “But the reason it makes perfect sense is that… bladder cancers don’t have viruses in them.” This revelation helps explain how a childhood infection can contribute to cancer decades later, even in the absence of detectable viral presence.
Future Research and Patient Hope
While these findings are promising, researchers emphasize that this is just a starting point. further examination is needed to determine whether BKV infection rates are higher in individuals with bladder cancer compared to those without the disease.
“It is intriguing,” said a researcher familiar with the study, “but only a starting point and work needs to be done to show it’s actual importance to human cancer.”
For individuals like Tim Tavender, a kidney transplant patient from Southampton who developed bladder cancer after a BKV infection, the research offers a glimmer of hope. “Seeing this research makes me hopeful,” Tavender told The Independent. “If scientists like Dr. Baker can find new ways to control BK virus, it could spare other people from going through what I did – and that would be life changing.”
The study underscores the complex interplay between viral infections, the immune system, and cancer development, perhaps opening new avenues for prevention and treatment strategies.
